and reduced efficacy of antimalarial drugs [2, 3] . The specific immunologic changes that may contribute to this increased susceptibility to malaria in HIV-positive pregnant women have not been characterized.
We recently demonstrated that elevated production of interferon (IFN)-g by intervillous blood mononuclear cells (IVBMCs) from multigravidae is associated with protection against placental malaria (PM) [5] . A role for IFN-g in protection against blood-stage malarial infection also has been suggested by others [6] . This led us to hypothesize that the loss of protection against PM in HIV-positive women may be due to impairment of IVBMC-mediated responses, particularly those involving IFN-g. To test this, we compared in vitro cytokine production by IVBMCs from HIV-positive and HIV-negative women, both with and without PM, in response to phytohemagglutinin (PHA), anti-CD3 monoclonal antibodies (MAbs), purified protein derivative (PPD), and malarial antigen stimulation.
Materials and Methods
Study site, participants, and samples. The study was conducted at the New Nyanza Provincial General Hospital in Kisumu, western Kenya. This area experiences intense perennial transmission of malaria, with peaks from November to December and May to July. Entomologic inoculation rates are 100-300/person/year [7] .
Women were enrolled into a cohort study designed to assess the impact of PM on mother-to-child transmission of HIV-1. The pres-ence of HIV-specific antibodies was determined antenatally, in serum from blood obtained by fingerprick, by Sero-Strip HIV-1/2 test kits (Saliva Diagnostic Systems, Vancouver, WA) and Capillus Rapid Test (HIV-1/HIV-2 antibodies; Trinity Biotech, Bray, Ireland). A positive result with either test was confirmed by Western blot; an indeterminate Western blot result served as an exclusion criterion. All participants were healthy, with no known infections or diseases (other than asymptomatic malaria and HIV infection).
Only women who experienced uncomplicated labor and singleton, vaginal, inpatient deliveries were included-a total of 224 women, gravida 1-8. Data for 72 subjects from the first report of this series [5] are included to maximize the strength of the present analyses. All were part of the same study population, and all samples were collected and processed in the same manner. Placentas were collected aseptically immediately after delivery. Evaluation of placental blood for malarial parasitemia was done by thick blood film [5] and was used as the basis for parasitemia categorization. All placenta collection and processing procedures, including isolation of IVBMCs, have been described elsewhere [5, 8] .
Culture of IVBMCs. IVBMCs were cultured and stimulated with PHA, anti-CD3 MAb, PPD, and soluble malarial antigen, as described elsewhere [5] . Culture supernatants were collected after 48 h and were stored at Ϫ80ЊC until testing.
Measurement of cytokine levels in supernatants by ELISA. Double-sandwich ELISAs were done, as described elsewhere [5] . Background cytokine production levels (from unstimulated cultures) were subtracted from stimulated culture values for each subject, to allow accurate assessment of the effect of the unique stimulants on cytokine production. Cytokine levels from cultures exposed to control red blood cell supernatant were subtracted from malarial antigen-stimulated cultures.
The levels of detection for the cytokines were 4 pg/mL for interleukin (IL)-4, 2 pg/mL for IL-10, and 8 pg/mL for IFN-g and tumor necrosis factor (TNF)-a.
Measurement of maternal peripheral CD4 T lymphocyte counts. CD4 T cell counts were determined in peripheral blood collected either late in pregnancy (132 weeks) or 1 month postpartum, by means of a standard flow cytometry protocol [9] , with reagents obtained from Becton Dickinson (San Jose, CA).
Organization and statistical analysis of data. Unless otherwise indicated, subjects were grouped according to infection status: HIV negative, PM negative; HIV negative, PM positive; HIV positive, PM negative; and HIV positive, PM positive. Because HIV infection is associated with increased susceptibility to PM, regardless of gravidity status, the data were analyzed on the basis of infection status only. SAS, version 6.12 (SAS Institute, Cary, NC), was used for data analysis. Comparisons of multiple groups were done by the Kruskal-Wallis test; statistically significant results obtained with the Kruskal-Wallis test were further tested by the Wilcoxon rank sum test, to assess differences between individual groups. Significance was concluded for . P р .05
Results

Study participant characteristics.
Clinical characteristics of the participants are summarized in table 1. There were no statistically significant differences in parasite densities between PM-positive groups or in age among any of the groups. Gravidity was significantly lower in the HIV negative, PM positive group.
IFN-g production by IVBMCs from HIV-negative and HIVpositive women. IVBMCs from HIV-positive persons were poor IFN-g producers, relative to their HIV-negative counterparts; HIV-positive, PM-negative IVBMCs produced the lowest levels in response to all stimulants (table 1). In malarial antigenand PPD-stimulated IVBMC cultures, HIV infection was associated with a substantial decline in the IFN-g response (all HIV-negative versus all HIV-positive, , Wilcoxon). P p .001 However, there was a moderate increase in IFN-g production in the HIV-positive, PM-positive group relative to the HIVpositive, PM-negative group.
IL-4 production by IVBMCs from HIV-negative and HIVpositive women.
IL-4 responses overall were low but were significantly higher in HIV-negative women-especially in the HIV-negative, PM-negative group-after PHA, anti-CD3 MAb (all HIV-negative versus all HIV-positive, , Wilcoxon), P ! .022 and malarial antigen stimulation (table 1) . In contrast, spontaneous and PPD-stimulated IL-4 production were elevated in the HIV-positive groups. (table 1) . In response to exogenous stimuli, HIV-positive, PM-negative IVBMCs produced higher levels of this cytokine (notably after anti-CD3 MAb and PPD stimulation) than did HIV-negative, PM-negative IVBMCs. The TNF-a response was highest in the HIV-positive, PM-positive group, especially after malarial antigen and PHA stimulation. Overall, PM appeared to exert a stronger influence over TNFa responses than did HIV infection (spontaneous production, PHA, and anti-CD3 MAb stimulation: all PM-positive versus all PM-negative, , Wilcoxon; malarial antigen stimu-P ! .014 lation: all PM-positive versus all PM-negative, , P p .025 Wilcoxon).
TNF-a production by IVBMCs from HIV-negative and HIVpositive women. Spontaneous production of TNF-a was vigorous in all groups
IL-10 production by IVBMCs from HIV-negative and HIVpositive women. Spontaneous IL-10 production was similar among groups. However, responses to PHA, anti-CD3 MAb, PPD, and malarial antigen were lower in the PM-positive groups, especially among HIV-positive, PM-positive women. In contrast, HIV-positive, PM-negative mothers showed enhanced responses to PPD and malarial antigen stimulation.
Cytokine production as a function of CD4 T cell counts. HIV-positive IVBMC cytokine production data were stratified by CD4 T cell count, with a cutoff of 500/mL, and reanalyzed. This cutoff is recommended by the Centers for Disease Control and Prevention for clinical classification of HIV-positive patients [10] . As shown in table 2, cytokine production was reduced in most cases when CD4 T cell counts were !500/mL. IFN-g and IL-4 responses to malarial antigen stimulation in the low CD4 cell count group were undetectable. In contrast, NOTE. Data are given as arithmetic mean ‫ע‬ SE (no. of subjects). Cytokines are expressed in pg/mL. IFN, interferon; PHA, phytohemagglutinin; PPD, purified protein derivative; IL, interleukin; TNF, tumor necrosis factor. a Parasite density was determined from thick blood film [5] and is expressed as parasites/mL of whole blood. production of TNF-a and IL-10 was enhanced in response to PPD stimulation in that group.
Discussion
HIV infection is associated with increased susceptibility to malaria during pregnancy [1] [2] [3] [4] , but the immunologic basis for this is not defined. We demonstrate here for the first time a substantial impairment of cytokine responses, most notably those of T cell-derived IFN-g, by IVBMCs from HIV-positive women. Considered together with our earlier demonstration of an association between IFN-g and protection against PM [5] , these findings suggest that there may be a causal relationship between disruption or dysregulation of IVBMC cytokine production and the increased prevalence and incidence of PM in HIV-positive women.
The impact of HIV infection on IFN-g production by IVBMCs was most evident in antigen-specific responses, especially in the HIV-positive, PM-negative group. Loss of IFNg responsiveness to malarial antigens in HIV-positive patients has been described elsewhere [11] . It is unclear why IFN-g production in response to PHA and anti-CD3 MAb stimulation was increased in HIV-positive, PM-positive women, but it is tempting to speculate that malarial infection further complicates the HIV-induced disequilibrium of cytokine networks in HIV-infected patients [12] , resulting in exaggerated nonspecific responses. It will be important to investigate the cellular sources of these cytokines and to consider other important regulatory cytokines, such as IL-12, to understand the basis for this dysregulation.
No dramatic influence of HIV infection on IVBMC IL-4 responses was observed. Again, this is in agreement with previous studies of peripheral blood mononuclear cells from African AIDS patients [11] . The role of IL-4 at the placental level in the context of HIV and malarial infections is not clear, however, and it is noteworthy that IL-4 responses were low overall, perhaps because of low responder frequencies or secretion levels. Thus, although both IFN-g and IL-4 are T cell-derived cytokines, expression of the former appears to be more significantly impaired by HIV infection and may be a more important determinant in susceptibility to PM.
The elevated production of TNF-a by the HIV-positive groups is consistent with the reported elevation of proinflammatory cytokine production in HIV-infected persons that is mediated by chronic activation of monocyte/macrophages [12] . These cells accumulate in the intervillous blood of malariaexposed women [13] and can be induced to produce TNF-a when exposed to malarial antigens [14] . Thus, this provides the most likely explanation for both the enhanced production of this cytokine in the context of PM, regardless of HIV status, and the high spontaneous production in all groups.
Spontaneous IL-10 production also was vigorous, perhaps in a counterregulatory response to the high levels of endogenous TNF-a production. In addition, the up-regulation of IL-10 responses by HIV-positive, PM-negative IVBMCs is consistent with the reported elevation of anti-inflammatory cytokine production by macrophages and T cells that accompanies proinflammatory cytokine dysregulation in HIV-infected persons [12] . The clear impairment of IL-10 production by HIV-positive, PM-positive persons, however, suggests that malarial infection might significantly disrupt this chronic, HIV-induced IL-10 production, perhaps via elevated, parasite-induced TNFa production.
Although a number of mechanisms may be involved in the impairment and dysregulation of cytokine production by IVBMCs from HIV-positive women, loss of CD4 T cells likely plays a central role. We observed dramatically reduced cytokine responses in women with CD4 T cell counts !500/mL. The most marked reductions were in IFN-g responses, particularly for spontaneous and malarial antigen-induced production. African AIDS patients with CD4 T cell counts !250/mL also had poor malarial antigen-stimulated IFN-g responses [11] . TNF-a and IL-10 production by IVBMCs was not as heavily affected, perhaps because of the chronic, HIV-associated activation of TNFa-and IL-10-producing monocytes and macrophages [12] that may increase in severity with decreasing CD4 T cell counts in this population.
The data presented here show that impaired cytokine responses to malaria (especially that of IFN-g, which is produced primarily by T cells) are found in the placentas of HIV-positive western Kenyan women and provide the first important clue regarding the immunologic changes that may contribute to the increased susceptibility of HIV-positive pregnant women to PM. However, other immune mechanisms that are essential for protection against malarial infection (e.g., antibody responses) also may be altered in HIV-positive women. Future studies that take into consideration the many other immunologic and biologic changes known to occur in HIV infection and pregnancy will be necessary to fully characterize the mechanisms underlying the increased susceptibility of HIV-positive pregnant women to malaria.
